Depletion of UCP1 and Myf5 population reduced xenograft growth.

Slides:

Advertisements

Similar presentations

Cell Physiol Biochem 2013;32: DOI: /

Advertisements

A, Effect of folate-FITC (500 nmol/kg, 5 days/week) and/or sunitinib (20 mg/kg daily) therapy on the growth of M109 tumors in Balb/c mice. A, Effect of.

Selinexor combines with immune checkpoint blockade to slow B16F10 melanoma tumor growth. Selinexor combines with immune checkpoint blockade to slow B16F10.

Supplementary Figure 2 Secondary transplanted brain tumors from PASC1 express human GH. Immuno-fluorescence staining of brain sections from mice implanted.

Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine

Expression of FUT9 supports tumor development

Effects of SC144 on in vivo ovarian tumor.

Fig. 4. Antitumor efficacy of ERY974 against various cancer types.

Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.

COX-2–PGE2 signaling is required for MSC-induced increase in ALDHhigh CSC-enriched population and tumor initiation. COX-2–PGE2 signaling is required for.

Effect of plumbagin (PL) on the growth of prostate tumors in Pten-KO mice. Effect of plumbagin (PL) on the growth of prostate tumors in Pten-KO mice. A.

Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.

Pharmacologic inhibition of eIF5A hypusination sensitizes KRas-driven tumor cells to MEK and KRas inhibition. Pharmacologic inhibition of eIF5A hypusination.

eIF5A-PEAK1 signaling regulates KRAS protein expression.

Src acetylation is critical for its tumorogenesis property.

Expression of p110γ isoform in macrophages promotes tumor growth and angiogenesis. Expression of p110γ isoform in macrophages promotes tumor growth and.

SW fraction induces S phase arrest and apoptosis.

Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal tumors. Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal.

Volume 16, Issue 6, Pages (June 2002)

CT-26 colon cancer induces the recruitment of protumor mast cells and the accumulation of MDSCs. CT-26 colon carcinoma cells (2 × 105) were injected s.c.

CD8 T cells play a critical role in responses of TILs due to BRAF inhibition. CD8 T cells play a critical role in responses of TILs due to BRAF inhibition.

Protracted temozolomide (TMZ) treatment leads to acquired TMZ resistance in glioblastoma (GBM) cells in vivo. Protracted temozolomide (TMZ) treatment leads.

In vivo assessment of synergistic activity of MV-CEA and RT in a U87 s

Effect of HA on hematopoietic recovery in tumor-bearing mice.

Conversion of CD11bhighCD27high NK cells into MDSCs leads to CD11bhighCD27high and CD11bhighCD27low NK cell reduction. Conversion of CD11bhighCD27high.

Antitumor activity of HER2-lytic hybrid peptide in tumor xenograft model in vivo. Antitumor activity of HER2-lytic hybrid peptide in tumor xenograft model.

SDF-1/CXCR4 axis is involved in CD133+ tumor cell metastasis toward a lymphatic metastasis niche. SDF-1/CXCR4 axis is involved in CD133+ tumor cell metastasis.

Tumor metastasis is mediated by neutrophils.

Expression of versican G3 domain enhanced breast cancer cell mammosphere formation. Expression of versican G3 domain enhanced breast cancer cell mammosphere.

In vivo growth-inhibitory effect of perifosine on bevacizumab-resistant CCC. A, the effect of bevacizumab (BEV) on CCC growth in vivo. In vivo growth-inhibitory.

Quercetin induces arrest in G1 phase of cell cycle in P39 xenografts.

Quercetin induces apoptosis in P39 xenografts.

Matriptase-2 inhibited breast tumor development in vivo.

Vascular staining in CWR22R xenograft tumors.

Transplantable HMLEHRASV12 xenografts show multilocular lipid droplets and express beige/brown adipocyte–specific proteins. Transplantable HMLEHRASV12.

Overexpression of DDB2 reduces invasive abilities in lungs of aggressive breast tumor cells. Overexpression of DDB2 reduces invasive abilities in lungs.

Active AR signaling in enzalutamide-resistant xenograft tumors.

GA reduces the growth of Caki-1 tumor xenografts.

In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. A,

ADU-S100–mediated tumor clearance is dependent on CD4+, CD8+ T cells, and NK cells. ADU-S100–mediated tumor clearance is dependent on CD4+, CD8+ T cells,

Antitumor effects of celastrol in vitro and in vivo.

MEDI4736 shows antitumor activity in xenograft mouse models of human cancer. MEDI4736 shows antitumor activity in xenograft mouse models of human cancer.

A protracted ketogenic diet increases radiation response in H292 lung cancer xenografts given conventional fractionated radiation. A protracted ketogenic.

The responses of H292 and A549 lung cancer xenografts to hypofractionated radiation were enhanced by the ketogenic diet. The responses of H292 and A549.

Expression of versican promoted breast cancer cell tumor formation and self-renewal in vivo. Expression of versican promoted breast cancer cell tumor formation.

Immunophenotypic analysis of TILs in B16 and K1735 melanoma following combination therapy with antibodies targeting PS and PD-1. Immunophenotypic analysis.

Effect of CDV on human SF7796 xenografts in vivo.

Whole-mount analysis of tumor induced lymphatic sprouting by confocal microscopy. Whole-mount analysis of tumor induced lymphatic sprouting by confocal.

Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8 and Stat3+/+:HPV8 mice. Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8.

Effect of SPINDLIN1 protein on cancer cell proliferation and invasion.

Effect of dietary feeding of silibinin on DU145 tumor xenograft growth in athymic male nude mice. Effect of dietary feeding of silibinin on DU145 tumor.

Expression of HO-1 by the FAP+/F4/80+ tumoral macrophages.

Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.

The CCR5+ population of SUM-159 cells is enriched with tumor-initiating cells. The CCR5+ population of SUM-159 cells is enriched with tumor-initiating.

SPARC is required for spontaneous metastasis

MGA271 exhibits potent in vivo antitumor activity toward tumor cell carcinoma xenografts. MGA271 exhibits potent in vivo antitumor activity toward tumor.

Effect of MZ treatment on lung colony formation in an experimental metastasis. Effect of MZ treatment on lung colony formation in an experimental metastasis.

Proliferation of TA3-Ha and TA3-St cells in vitro and in vivo.

Immune checkpoint molecule expression in primary and secondary tumors following radiotherapy. Immune checkpoint molecule expression in primary and secondary.

BMX is a driver of castration resistance in vitro and in vivo.

Immune response of CEA-transgenic mice transferred with OT-1 splenocytes and immunized with ovalbumin and adjuvant. Immune response of CEA-transgenic mice.

Anti–TGF-β1 antibody neutralizes APB-mediated immune suppression.

Mutation of the Smad3 linker phosphorylation sites in 4T1 cells reduces putative stem cell population and tumor initiating frequency of cells from the.

IL35 regulation of tumor growth is accompanied by suppression of CD4+ effector T-cell activity and expansion of Tregs. IL35 regulation of tumor growth.

W. chinensis extract attenuates tumor growth of 103E (a subline of CWR22Rv1) engrafted in the prostate of nude mice. W. chinensis extract attenuates tumor.

Transgenic mice with constitutively active NIK show increased tumor growth in bone. Transgenic mice with constitutively active NIK show increased tumor.

MSCs elicit EMT, invasion of carcinoma cells, and increased tumor initiation of xenografts. MSCs elicit EMT, invasion of carcinoma cells, and increased.

MDSC population in patient peripheral blood.

EC-derived SP cells are targeted by CD30.CAR T cells.

DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.

Presentation transcript:

Depletion of UCP1 and Myf5 population reduced xenograft growth. Depletion of UCP1 and Myf5 population reduced xenograft growth. A, cells (2 × 106) from primary HMLEHRASV12 xenografts was mixed with Matrigel (1:1) and implanted at a subcutaneous site (posterior dorsolateral) in nude mice (n = 8). Five weeks after implantation of cells, the mice were killed, tumors were excised and dissociated. Dissociated cells (2 × 107) from each of the eight xenografts were individually sorted by FACS into UCP1+ and UCP1− populations. From each of the xenografts, control unsorted (2 × 106) or UCP1− (2 × 106) fraction of the sorted cells were injected subcutaneously (posterior dorsolateral) into nude mice (n = 8). After 10 weeks, the mice were killed, tumors were excised and tumor weight was measured. B, cells (2 × 106) from 7- and 15-week xenografts were injected into nude mice (subcutaneously, posterior dorsolateral; n = 3, per group per time point). Mice were killed, xenografts were excised, and weighed at each of the time points. Data are presented as mean ± SD. (*, P < 0.05; **, P < 0.01). C, cells from dissociated xenografts (1- and 3-week) were subjected to flow cytometry to determine the percentage of ALDH1 (ALDH1 Ab /FITC) as well as ALDH1/PRDM16 (ALDH1 Ab /FITC, PRDM16 Ab/Texas Red) coexpressing cells. D, paraffin-embedded sections of xenografts were immunolabeled for Myf5 and a representative picture is shown. Arrows show Myf5-stained cells. E, Myf5-expressing cells in the dissociated xenografts can be sorted by labeling with Myf5-FITC Abs. A representative picture is shown. F, dissociated cells (2 × 107) from xenografts (1–3 weeks) was sorted by FACS into Myf5+ and Myf5− populations. Control unsorted (2 × 106) or Myf5− (2 × 106) fraction of the sorted cells were injected subcutaneously (posterior dorsolateral) into nude mice (n = 5). After 4 weeks, the mice were killed, tumors were excised, and tumor weight was measured. Data are presented as mean ± SD (*, P < 0.05; **, P < 0.01). Rajan Singh et al. Mol Cancer Res 2016;14:78-92 ©2016 by American Association for Cancer Research